The intermediate syndrome is a specific neurological complication following organophosphate poisoning.
This syndrome typically emerges 24 to 96 hours after exposure, after the initial acute cholinergic symptoms have subsided.
It is characterized by:
Understanding the timing and symptoms helps differentiate:
The clinical presentation of cranial nerve and brain stem lesions is the defining feature of the intermediate syndrome in organophosphate poisoning.
Consider the following statements regarding organophosphate-induced delayed polyneuropathy (OPIDN) :
1. It is a rare complication and occurs 2 - 3 weeks after acute exposure.
2. It is a feature of poisoning with certain organophosphorus compounds such as triorthocresyl phosphate.
3. Inhibition of acetylcholinesterase causes motor polyneuropathy with no evidence of sensory loss.
4. There is no specific therapy although regular physiotherapy may limit deformity caused by muscle wasting.
Which of the statements given above are correct?
Which of the following parts of the human body can be used as a sample/samples for the presence of mercury?
1. Blood
2. Hair
3. Nail
Select the correct answer using the code given below: